Staging Candidiasis in ICU Patients

Centre Hospitalier Universitaire de Nīmes

Status: Completed

Conditions: Candidiasis

Treatments: Biological: Tests for candidiasis

Study type: Observational

Funder types: Other

Identifiers

NCT01322698

2010-A00858-31 (Other Identifier)

AOI/2009/BL-01

Details and patient eligibility

About

Our primary objective is to evaluate the relevance of the early determination of Candida infection status among non-neutropenic patients hospitalized over 48 hours in ICUs.

Enrollment: 422 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Polynuclear neutrophils > 500/mm^3
• Hospitalized for > 48 hours in participating ICUs

Exclusion criteria

• Patients discharged from ICU in < 48h
• Patient diagnosed with invasive candidosis before entry to ICU
• Patient is taking an anti-fungal treatment
• polynuclear neutrophils < 500/mm^3
• patient transferred to another ICU
• patient included in the Abmidex protocole

Trial design

422 participants in 1 patient group

The study population

Description:

The target population includes patients in ICUs at the Nîmes and Montpellier University hospitals. This is a population of non-neutropenic patients (polynuclear neutrophils \> 500/mm3) at risk of developing invasive candidiasis.

Treatment:

Biological: Tests for candidiasis